These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19824919)

  • 1. T-helper 1 and T-helper 2 adjuvants induce distinct differences in the magnitude, quality and kinetics of the early inflammatory response at the site of injection.
    Korsholm KS; Petersen RV; Agger EM; Andersen P
    Immunology; 2010 Jan; 129(1):75-86. PubMed ID: 19824919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Babassu aqueous extract (BAE) as an adjuvant for T helper (Th)1-dependent immune responses in mice of a Th2 immune response-prone strain.
    Guerra RN; Silva VM; Aragão-França LS; Oliveira PR; Feitosa R; Nascimento FR; Pontes-de-Carvalho LC
    BMC Immunol; 2011 Jan; 12():13. PubMed ID: 21276258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th1 immune responses can be modulated by varying dimethyldioctadecylammonium and distearoyl-sn-glycero-3-phosphocholine content in liposomal adjuvants.
    Hussain MJ; Wilkinson A; Bramwell VW; Christensen D; Perrie Y
    J Pharm Pharmacol; 2014 Mar; 66(3):358-66. PubMed ID: 24251796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of monophosphoryl lipid A (MPL) on T-helper cells when administered as an adjuvant with pneumocococcal-CRM197 conjugate vaccine in healthy toddlers.
    Vernacchio L; Bernstein H; Pelton S; Allen C; MacDonald K; Dunn J; Duncan DD; Tsao G; LaPosta V; Eldridge J; Laussucq S; Ambrosino DM; Molrine DC
    Vaccine; 2002 Nov; 20(31-32):3658-67. PubMed ID: 12399193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog.
    Christensen D; Henriksen-Lacey M; Kamath AT; Lindenstrøm T; Korsholm KS; Christensen JP; Rochat AF; Lambert PH; Andersen P; Siegrist CA; Perrie Y; Agger EM
    J Control Release; 2012 Jun; 160(3):468-76. PubMed ID: 22709414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of survivin-specific anti-tumor immunity by adenovirus prime protein-boost immunity strategy with DDA/MPL adjuvant in a murine melanoma model.
    Wang YQ; Zhang HH; Liu CL; Wu H; Wang P; Xia Q; Zhang LX; Li B; Wu JX; Yu B; Gu TJ; Yu XH; Kong W
    Int Immunopharmacol; 2013 Sep; 17(1):9-17. PubMed ID: 23624214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Immunogenicity and Protective Efficacy of a
    Ramakrishnan A; Schumack NM; Gariepy CL; Eggleston H; Nunez G; Espinoza N; Nieto M; Castillo R; Rojas J; McCoy AJ; Beck Z; Matyas GR; Alving CR; Guerry P; Poly F; Laird RM
    mSphere; 2019 May; 4(3):. PubMed ID: 31043512
    [No Abstract]   [Full Text] [Related]  

  • 8. The adjuvant combination monophosphoryl lipid A and QS21 switches T cell responses induced with a soluble recombinant HIV protein from Th2 to Th1.
    Moore A; McCarthy L; Mills KH
    Vaccine; 1999 Jun; 17(20-21):2517-27. PubMed ID: 10418898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivalent presentation of MPL by porous silicon microparticles favors T helper 1 polarization enhancing the anti-tumor efficacy of doxorubicin nanoliposomes.
    Meraz IM; Hearnden CH; Liu X; Yang M; Williams L; Savage DJ; Gu J; Rhudy JR; Yokoi K; Lavelle EC; Serda RE
    PLoS One; 2014; 9(4):e94703. PubMed ID: 24736547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pegylation of DDA:TDB liposomal adjuvants reduces the vaccine depot effect and alters the Th1/Th2 immune responses.
    Kaur R; Bramwell VW; Kirby DJ; Perrie Y
    J Control Release; 2012 Feb; 158(1):72-7. PubMed ID: 22032883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of Bacillus subtilis spores and monophosphoryl lipid A as adjuvants of protein-based mycobacterium tuberculosis-based vaccines: partial requirement for interleukin-17a for induction of protective immunity.
    Esparza-Gonzalez SC; Troy AR; Izzo AA
    Clin Vaccine Immunol; 2014 Apr; 21(4):501-8. PubMed ID: 24477855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of the TLR4 agonist monophosphoryl lipid A into the bilayer of DDA/TDB liposomes: physico-chemical characterization and induction of CD8+ T-cell responses in vivo.
    Nordly P; Agger EM; Andersen P; Nielsen HM; Foged C
    Pharm Res; 2011 Mar; 28(3):553-62. PubMed ID: 21042837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of Aluminum Hydroxide and Monophosphoryl Lipid A Adjuvants in Overcoming CD4+ T Cell Deficiency To Induce Isotype-Switched IgG Antibody Responses and Protection by T-Dependent Influenza Vaccine.
    Ko EJ; Lee YT; Kim KH; Lee Y; Jung YJ; Kim MC; Lee YN; Kang T; Kang SM
    J Immunol; 2017 Jan; 198(1):279-291. PubMed ID: 27881702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel adjuvant G3 induces both Th1 and Th2 related immune responses in mice after immunization with a trivalent inactivated split-virion influenza vaccine.
    Hjertner B; Bengtsson T; Morein B; Paulie S; Fossum C
    Vaccine; 2018 May; 36(23):3340-3344. PubMed ID: 29706292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT4 is required for the generation of Th1 and Th2, but not Th17 immune responses during monophosphoryl lipid A adjuvant activity.
    Varikuti S; Oghumu S; Natarajan G; Kimble J; Sperling RH; Moretti E; Kaplan MH; Satoskar AR
    Int Immunol; 2016 Nov; 28(11):565-570. PubMed ID: 27578456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen dose defines T helper 1 and T helper 2 responses in the lungs of C57BL/6 and BALB/c mice independently of splenic responses.
    Morokata T; Ishikawa J; Yamada T
    Immunol Lett; 2000 May; 72(2):119-26. PubMed ID: 10841947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell recruitment and cytokines in skin mice sensitized with the vaccine adjuvants: saponin, incomplete Freund's adjuvant, and monophosphoryl lipid A.
    Vitoriano-Souza J; Moreira Nd; Teixeira-Carvalho A; Carneiro CM; Siqueira FA; Vieira PM; Giunchetti RC; Moura SA; Fujiwara RT; Melo MN; Reis AB
    PLoS One; 2012; 7(7):e40745. PubMed ID: 22829882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity.
    Didierlaurent AM; Morel S; Lockman L; Giannini SL; Bisteau M; Carlsen H; Kielland A; Vosters O; Vanderheyde N; Schiavetti F; Larocque D; Van Mechelen M; Garçon N
    J Immunol; 2009 Nov; 183(10):6186-97. PubMed ID: 19864596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The low-toxicity versions of LPS, MPL adjuvant and RC529, are efficient adjuvants for CD4+ T cells.
    Thompson BS; Chilton PM; Ward JR; Evans JT; Mitchell TC
    J Leukoc Biol; 2005 Dec; 78(6):1273-80. PubMed ID: 16204643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of ovalbumin-specific Th1, Th2, and Th17 immune responses by amorphous silica nanoparticles.
    Toda T; Yoshino S
    Int J Immunopathol Pharmacol; 2016 Sep; 29(3):408-20. PubMed ID: 27343242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.